Literature DB >> 23654061

Treatment of resistant bacterial infections in children: thinking inside and outside the box.

Gilat Livni1, Shai Ashkenazi.   

Abstract

Antimicrobial resistance of bacteria causing pediatric infections has become more common and complicated in recent years. Although formerly confined to hospital settings, multi-drug resistant bacteria now also cause community-acquired infections. Treatment of infections caused by resistant pathogens is difficult, necessitating thinking both inside and outside the box. Determination of the precise minimal inhibitory concentration (MIC) is often crucial for selecting the most appropriate antibiotics, their doses, and use of prolonged infusions. For some multiply-resistant bacteria, off-label use of antibiotics, sometimes with no evidence from controlled studies ("salvage therapy") is unavoidable.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23654061     DOI: 10.1007/978-1-4614-4726-9_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.

Authors:  Fouad Madhi; Camille Jung; Sandra Timsit; Corinne Levy; Sandra Biscardi; Mathie Lorrot; Emmanuel Grimprel; Laure Hees; Irina Craiu; Aurelien Galerne; François Dubos; Emmanuel Cixous; Véronique Hentgen; Stéphane Béchet; Stéphane Bonacorsi; Robert Cohen
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

2.  Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.

Authors:  Gabriel Lignieres; André Birgy; Camille Jung; Stéphane Bonacorsi; Corinne Levy; François Angoulvant; Emmanuel Grimprel; Marie Aliette Dommergues; Yves Gillet; Irina Craiu; Alexis Rybak; Loic De Pontual; François Dubos; Emmanuel Cixous; Vincent Gajdos; Didier Pinquier; Isabelle Andriantahina; Valérie Soussan-Banini; Emilie Georget; Elise Launay; Olivier Vignaud; Robert Cohen; Fouad Madhi
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.